Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats

Journal of Clinical Investigation

Volumn 119, Issue 5, 2009, Pages 1150-1158

  Novak, Kevin R ^a   Nardelli, Paul ^a   Cope, Tim C ^a   Filatov, Gregory ^a   Glass, Jonathan D ^b   Khan, Jaffar ^b   Rich, Mark M ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CREATININE; GLUCOSE; POTASSIUM; SODIUM; VOLTAGE GATED SODIUM CHANNEL; ELECTROLYTE; SODIUM CHANNEL;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DEMYELINATION; DISEASE ACTIVITY; DORSAL ROOT; DOWN REGULATION; ELECTROLYTE DISTURBANCE; FEMALE; HUMAN; HYPERPOLARIZATION; IN VIVO STUDY; INTRACELLULAR RECORDING; MEMBRANE STEADY POTENTIAL; NERVE CONDUCTION; NERVE DEGENERATION; NERVE FIBER; NERVE POTENTIAL; NERVE STIMULATION; NEUROPATHY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT; SEPSIS; SODIUM CHANNELOPATHY; ACTION POTENTIAL; ANIMAL; BLOOD; CELL MEMBRANE; CELL MEMBRANE POTENTIAL; CHANNELOPATHY; ELECTROMYOGRAPHY; IMPEDANCE; MOTONEURON; MUSCLE DISEASE; MUSCLE WEAKNESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYNEUROPATHY; SENSORY RECEPTOR; WISTAR RAT;

ACTION POTENTIALS; ANIMALS; CELL MEMBRANE; CHANNELOPATHIES; CRITICAL ILLNESS; ELECTRIC IMPEDANCE; ELECTROLYTES; ELECTROMYOGRAPHY; FEMALE; HUMANS; MEMBRANE POTENTIALS; MOTOR NEURONS; MUSCLE WEAKNESS; MUSCULAR DISEASES; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; POLYNEUROPATHIES; RATS; RATS, WISTAR; SENSORY RECEPTOR CELLS; SEPSIS; SODIUM CHANNELS;

EID: 66449128310     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI36570     Document Type: Article

References (60)

1. Herridge, M.S., et al. 2003. One-year outcomes in survivors of the acute respiratory distress syndrome. N. Engl. J. Med. 348:683-693.
2. Bolton, C.F. 2005. Neuromuscular manifestations of critical illness. Muscle Nerve. 32:140-163.
3. Schweickert, W.D., and Hall, J. 2007. ICU-acquired weakness. Chest. 131:1541-1549.
4. Stevens, R.D., et al. 2007. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 33:1876-1891.
5. Lacomis, D., Zochodne, D.W., and Bird, S.J. 2000. Critical illness myopathy. Muscle Nerve. 23:1785-1788.
6. Khan, J., Harrison, T.B., and Rich, M.M. 2008. Mechanisms of neuromuscular dysfunction in critical illness. Crit. Care Clin. 24:165-177.
7. Teener, J.W., and Rich, M.M. 2006. Dysregulation of sodium channel gating in critical illness myopathy. J. Muscle Res. Cell Motil. 27:291-296.
8. Bolton, C.F., Gilbert, J.J., Hahn, A.F., and Sibbald, W.J. 1984. Polyneuropathy in critically ill patients. J. Neurol. Neurosurg. Psychiatry. 47:1223-1231.
9. Bolton, C.F., et al. 1986. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barre syndrome. J. Neurol. Neurosurg. Psychiatry. 49:563-573.
10. Zochodne, D.W., et al. 1987. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain. 110:819-841.
11. Latronico, N., et al. 1996. Critical illness myopathy and neuropathy. Lancet. 347:1579-1582.
12. Z'Graggen, W.J., Lin, C.S., Howard, R.S., Beale, R.J., and Bostock, H. 2006. Nerve excitability changes in critical illness polyneuropathy. Brain. 129:2461-2470.
13. Griffin, J.W., and Hoffman, P.N. 1993. Degeneration and regeneration in the peripheral nervous system. In Peripheral neuropathy. P.J. Dyck, P.K. Thomas, J.W. Griffin, P.A. Low, and J.F. Poduslo, editors. W.B. Saunders. Philadelphia, Pennsylvania, USA. 361-376.
14. Khan, J., Harrison, T.B., Rich, M.M., and Moss, M. 2006. Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology. 67:1421-1425.
15. Tennila, A., et al. 2000. Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med. 26:1360-1363.
16. Tepper, M., Rakic, S., Haas, J.A., and Woittiez, A.J. 2000. Incidence and onset of critical illness polyneuropathy in patients with septic shock. Neth. J. Med. 56:211-214.
17. Nayci, A., et al. 2005. Sepsis induces early phrenic nerve neuropathy in rats. Eur. Respir. J. 26:686-692.
18. Cankayali, I., et al. 2007. Neuromuscular deterioration in the early stage of sepsis in rats. Crit. Care. 11:R1.
19. Spitzer, A.R., Giancarlo, T., Maher, L., Awerbuch, G., and Bowles, A. 1992. Neuromuscular causes of prolonged ventilator dependency. Muscle Nerve. 15:682-686.
20. Leijten, F.S., Harinck-de Weerd, J.E., Poortvliet, D.C., and de Weerd, A.W. 1995. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA. 274:1221-1225.
21. Leijten, F.S., and de Weerd, A.W. 1996. Critical illness polyneuropathy, facts and controversies. J. Peripher. Nerv. Syst. 1:28-33.
22. Chaudhry, V., Glass, J.D., and Griffin, J.W. 1992. Wallerian degeneration in peripheral nerve disease. Neurol. Clin. 10:613-627.
23. David, G., Modney, B., Scappaticci, K.A., Barrett, J.N., and Barrett, E.F. 1995. Electrical and morphological factors influencing the depolarizing after-potential in rat and lizard myelinated axons. J. Physiol. 489:141-157.
24. Bird, S.J., and Rich, M.M. 2002. Critical illness myopathy and polyneuropathy. Curr. Neurol. Neurosci. Rep. 2:527-533.
25. White, B.H., et al. 2001. Targeted attenuation of electrical activity in Drosophila using a genetically modified K(+) channel. Neuron. 31:699-711.
26. + current types. J. Neurophysiol. 68:1001-1011.
27. Harty, T.P., et al. 2006. Na(V)1.7 mutant A863P in erythromelalgia: effects of altered activation and steady-state inactivation on excitability of nociceptive dorsal root ganglion neurons. J. Neurosci. 26:12566-12575.
28. Cannon, S.C. 2002. An expanding view for the molecular basis of familial periodic paralysis. Neuromuscul. Disord. 12:533-543.
29. Rich, M.M., and Pinter, M.J. 2001. Sodium channel inactivation in an animal model of acute quadriplegic myopathy. Ann. Neurol. 50:26-33.
30. Rich, M.M., and Pinter, M.J. 2003. Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J. Physiol. 547:555-566.
31. McCarthy, P.W., and Lawson, S.N. 1997. Differing action potential shapes in rat dorsal root ganglion neurones related to their substance P and calcitonin gene-related peptide immunoreactivity. J. Comp. Neurol. 388:541-549.
32. Xu, Z.Q., Zhang, X., Grillner, S., and Hokfelt, T. 1997. Electrophysiological studies on rat dorsal root ganglion neurons after peripheral axotomy: changes in responses to neuropeptides. Proc. Natl. Acad. Sci. U. S. A. 94:13262-13266.
33. Abraham, S., Beatch, G.N., MacLeod, B.A., and Walker, M.J. 1989. Antiarrhythmic properties of tetrodotoxin against occlusion-induced arrhythmias in the rat: a novel approach to the study of the antiarrhythmic effects of ventricular sodium channel blockade. J. Pharmacol. Exp. Ther. 251:1166-1173.
34. Filatov, G.N., and Rich, M.M. 2004. Hyperpolarized shifts in the voltage dependence of fast inactivation of Nav1.4 and Nav1.5 in a rat model of critical illness myopathy. J. Physiol. 559:813-820.
35. Guttman, R., and Hachmeister, L. 1972. Anode break excitation in space-clamped squid axons. Biophys. J. 12:552-563.
36. Waxman, S.G. 2006. Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat. Rev. Neurosci. 7:932-941.
37. Goldin, A.L. 2001. Resurgence of sodium channel research. Annu. Rev. Physiol. 63:871-894.
38. Waxman, S.G. 2001. Transcriptional channelopathies: an emerging class of disorders. Nat. Rev. Neurosci. 2:652-659.
39. Bennett, E.S. 2002. Isoform-specific effects of sialic acid on voltage-dependent Na+ channel gating: functional sialic acids are localized to the S5-S6 loop of domain I. J. Physiol. 538:675-690.
40. Rossie, S. 1999. Regulation of voltage-sensitive sodium and calcium channels by phosphorylation. Adv. Second Messenger Phosphoprotein Res. 33:23-48.
41. + channels: an unexpected form of cellular plasticity. Nat. Rev. Neurosci. 2:397-407.
42. Chahine, M., Ziane, R., Vijayaragavan, K., and Okamura, Y. 2005. Regulation of Na v channels in sensory neurons. Trends Pharmacol. Sci. 26:496-502.
43. Wang, D.W., George, A.L., Jr., and Bennett, P.B. 1996. Comparison of heterologously expressed human cardiac and skeletal muscle sodium channels. Biophys. J. 70:238-245.
44. Filatov, G.N., Pinter, M.J., and Rich, M.M. 2005. Resting potential-dependent regulation of the voltage sensitivity of sodium channel gating in rat skeletal muscle in vivo. J. Gen. Physiol. 126:161-172.
45. Wittmack, E.K., Rush, A.M., Hudmon, A., Waxman, S.G., and Dib-Hajj, S.D. 2005. Voltage-gated sodium channel Nav1.6 is modulated by p38 mitogenactivated protein kinase. J. Neurosci. 25:6621-6630.
46. Jensen, R.A., and Katzung, B.G. 1970. Electrophysiological actions of diphenylhydantoin on rabbit atria. Dependence on stimulation frequency, potassium, and sodium. Circ. Res. 26:17-27.
47. Singh, B.N., and Williams, E.M. 1971. Effect of altering potassium concentration on the action of lidocaine and diphenylhydantoin on rabbit atrial and ventricular muscle. Circ. Res. 29:286-295.
48. de Seze, M., et al. 2000. Critical illness polyneuropathy. A 2-year follow-up study in 19 severe cases. Eur. Neurol. 43:61-69.
49. Rich, M.M., Teener, J.W., Raps, E.C., Schotland, D.L., and Bird, S.J. 1996. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology. 46:731-736.
50. Rich, M.M., Bird, S.J., Raps, E.C., McCluskey, L.F., and Teener, J.W. 1997. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve. 20:665-673.
51. Rich, M.M., Pinter, M.J., Kraner, S.D., and Barchi, R.L. 1998. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann. Neurol. 43:171-179.
52. Rich, M.M., Kraner, S.D., and Barchi, R.L. 1999. Altered gene expression in steroid-treated denervated muscle. Neurobiol. Dis. 6:515-522.
53. Caffrey, J.M., Eng, D.L., Black, J.A., Waxman, S.G., and Kocsis, J.D. 1992. Three types of sodium channels in adult rat dorsal root ganglion neurons. Brain Res. 592:283-297.
54. Angaut-Petit, D., et al. 1982. Electrophysiological and morphological studies of a motor nerve in 'motor endplate disease' of the mouse. Proc. R. Soc. Lond. B Biol. Sci. 215:117-125.
55. de Letter, M.A., et al. 2001. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit. Care Med. 29:2281-2286.
56. Bednarik, J., Lukas, Z., and Vondracek, P. 2003. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med. 29:1505-1514.
57. Bednarik, J., Vondracek, P., Dusek, L., Moravcova, E., and Cundrle, I. 2005. Risk factors for critical illness polyneuromyopathy. J. Neurol. 252:343-351.
58. Bernard, G.R., et al. 2001. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344:699-709.
59. Haftel, V.K., et al. 2005. Central suppression of regenerated proprioceptive afferents. J. Neurosci. 25:4733-4742.
60. Glass, J.D., and Griffin, J.W. 1991. Neurofilament redistribution in transected nerves: evidence for bidirectional transport of neurofilaments. J. Neurosci. 11:3146-3154.